aced126
Bluelighter
- Joined
- May 18, 2015
- Messages
- 1,047
Does anyone know of any studies evaluating the pharmacophore requirements of antagonist activity at MOR? What made me think about this was the following:
Naltrexone: full antagonist
Nalbuphine: partial agonist (intrinsic activity = 47% )
My questions:
1) Does substitution at carbon 6 affect intrinsic activity?
2) Is it such that a cyclobutylmethyl subsitution increases intrinsic activity from 0 (antagonist) to almost 50% (agonist).
I'll edit more in time.
Naltrexone: full antagonist
Nalbuphine: partial agonist (intrinsic activity = 47% )
My questions:
1) Does substitution at carbon 6 affect intrinsic activity?
2) Is it such that a cyclobutylmethyl subsitution increases intrinsic activity from 0 (antagonist) to almost 50% (agonist).
I'll edit more in time.